Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
Human semen spontaneously coagulates into a semisolid mass and then wholly liquefies in a process that may have some similarity to that of normal blood. This well described phenomenon is referred to as coagulation and liquefaction of semen. Besides other active components of the haemostatic system, semen contains a significant amount of functional tissue factor (TF). However, TF needs factor (F)VII in order to exert it actions. In this study, we assessed human semen for the presence of FVII and FVIIa, and related their levels to conventional fertility parameters. Using a functional, one stage, clotting assay based upon the prolongation of the prothrombin clotting time, using the ACL 300R analyser and an Imubind FVIIa ELISA assay, FVII and FVIIa levels were measured in 97 semen specimens obtained from sub-fertile (sperm counts <20 x 10(6)/mL), normally fertile (sperm counts >or=20 x 10(6) but <60 x 10(6)/mL), fertile sperm donors (sperm counts >or=60 x 10(6)/mL), vasectomized subjects and in a pooled normal semen parameters group (categorization into groups was based on the World Health Organization guidelines on fertility criteria). In addition, conventional semen parameters were analysed on all semen samples. Both FVII and FVIIa were quantifiable in human semen. The mean levels of FVII and FVIIa were 4.4 IU/dL and 12 ng/mL respectively. Despite the observed variations of FVIIa levels in the studied groups they did not meet statistical significance when the groups were tested against each other. However, seminal FVIIa levels showed a significant positive association with semen liquefaction time, sperm motility and semen volume. The anti-sperm antibodies and sperm-agglutination groups were also associated with raised seminal FVIIa levels. We observed no significant relationship between FVIIa levels and total sperm concentration, sperm count per mL (sperm density), sperm progression and days of sexual abstinence. This study demonstrates that human semen contains appreciable amounts of FVII and FVIIa. It is possible to quantify these using commercially available assays. There also appears to be a direct correlation between the levels of these factors and certain seminal parameters. This finding reinforces the concept of an active clotting system in human semen, by establishing the missing link in the activation of a TF-dependent pathway.
Lwaleed
Bashir A
BA
Department of Urology, Southampton University Hospitals NHS Trust, Southampton, UK. bashir@soton.ac.uk
Goyal
Anuj
A
Delves
George
G
Gossai
Sunil
S
Greenfield
Robert S
RS
Cooper
Alan J
AJ
D001323:Autoantibodies / Q000032:analysis; D005167:Factor VII / Q000032:analysis*; D015942:Factor VIIa / Q000032:analysis*; D005298:Fertility / Q000502:physiology*; D006801:Humans; D008297:Male; D012661:Semen / Q000737:chemistry*; D029607:Seminal Vesicle Secretory Proteins / Q000032:analysis*; D012746:Sexual Abstinence; D013073:Sperm Agglutination; D013076:Sperm Count; D013081:Sperm Motility; D013094:Spermatozoa / Q000276:immunology / Q000502:physiology*; D013925:Thromboplastin / Q000032:analysis*; D014659:Vasectomy
D001323:Autoantibodies; D029607:Seminal Vesicle Secretory Proteins; D005167:Factor VII; D013925:Thromboplastin; D015942:Factor VIIa